Cancer
Malignant Gastric Neoplasm
CI-CAN-00001130Explore in graph →
Top-level652 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001130Explore in graph →
Clinical trials
2,842 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (232)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01158287 | Sorafenib. ICORG 06-41, V4 | completed | Phase 2 | 54 | Cancer Trials IrelandNETWORK | 1 | Dec 31, 2014 | clinicaltrials |
| NCT00253370 | Sorafenib, Docetaxel, and Cisplatin in Treating Patients With Metastatic or Advanced Gastric or Gastroesophageal Junction Cancer | completed | Phase 2 | 44 | National Cancer Institute (NCI)NIH | 1 | Nov 24, 2014 | clinicaltrials |
| NCT01497964 |
| Cabazitaxel in Asian Patients With Advanced Gastric Cancer Who Failed Prior Chemotherapy(GASTANA) |
| completed |
| Phase 1 / Phase 2 |
| 16 |
| SanofiINDUSTRY |
| 1 |
| Nov 10, 2014 |
| clinicaltrials |
| NCT01567618 | Dose-dense Biweekly Docetaxel Combined With 5-fluorouracil as First-line Treatment in Advanced Gastric Cancer(DaeMon) | completed | Phase 2 | 39 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Nov 7, 2014 | clinicaltrials |
| NCT01138904 | FOLFOX Followed by FOLFIRI or Reverse Sequence Treatment in Advanced Gastric Cancer (AGC) | completed | Phase 2 | 80 | Dong-A University HospitalOTHER | 1 | Nov 4, 2014 | clinicaltrials |
| NCT01246960 | A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer | completed | Phase 2 | 168 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 8, 2014 | clinicaltrials |
| NCT00006389 | Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer | completed | Phase 2 | 12 | National Cancer Institute (NCI)NIH | 1 | Oct 1, 2014 | clinicaltrials |
| NCT02233712 | Open-label, Dose-finding Study to Determine Antibody Response to G17DT Treatment in Patients With Gastric Cancer.(GC3) | completed | Phase 2 | 33 | Cancer Advances Inc.INDUSTRY | 0 | Sep 8, 2014 | clinicaltrials |
| NCT00991952 | Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach or Gastroesophageal Junction Cancer That Cannot Be Removed By Surgery | completed | Phase 2 | 19 | National Cancer Institute (NCI)NIH | 1 | May 26, 2014 | clinicaltrials |
| NCT00183911 | Study of 5-Fluorouracil and Leucovorin and Intra-abdominal Floxuridine Chemoradiation in Patients With Fully Resected Locally Advanced Gastric Adenocarcinoma | completed | Phase 2 | 25 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT01379482 | Neo-adjuvant Chemo + Peritonectomy + Hyperthermic Intraperitoneal Chemo in Peritoneal Carcinomatosis From Gastric Cancer | completed | Phase 2 | 18 | Uppsala UniversityOTHER | 1 | May 6, 2014 | clinicaltrials |
| NCT01444521 | Genotype-drive Study of Irinotecan-Cisplatin Combination for Advanced Gastric Cancer | completed | Phase 2 | 50 | Chinese Academy of Medical SciencesOTHER | 1 | May 6, 2014 | clinicaltrials |
| NCT02048540 | Neoadjuvant Bev Plus DOF vs DOF in LAGC and Its Association With Circulating Tumor Cell | completed | Phase 1 / Phase 2 | 86 | Chinese PLA General HospitalOTHER | 1 | Apr 25, 2014 | clinicaltrials |
| NCT01672333 | Response Rate and Side Effects of Preoperative Chemotherapy (TOX Regimen) in Patients With Locally Advanced Operable Gastric Adenocarcinoma(TOX) | completed | Phase 2 | 50 | Milad HospitalOTHER | 1 | Mar 20, 2014 | clinicaltrials |
| NCT02090153 | Study of S-1 Plus LV for Advanced Gastric Cancer | completed | Phase 2 | 39 | Sun Yat-sen UniversityOTHER | 1 | Mar 18, 2014 | clinicaltrials |
| NCT00278863 | Capecitabine Versus S-1 in Elderly Advanced Gastric Cancer (AGC): Randomized Trial | completed | Phase 2 | 96 | Asan Medical CenterOTHER | 1 | Feb 25, 2014 | clinicaltrials |
| NCT02071043 | Trial of Xeloda and Oxaliplatin (XELOX) as Neo-adjuvant Chemotherapy Followed by Surgery in Advanced Gastric Cancer Patients With Para-aortic Lymph Node Metastasis | completed | Phase 2 | 48 | Shanghai Zhongshan HospitalOTHER | 1 | Feb 25, 2014 | clinicaltrials |
| NCT00719550 | AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer | completed | Phase 1 / Phase 2 | 130 | AmgenINDUSTRY | 0 | Dec 5, 2013 | clinicaltrials |
| NCT00464893 | Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection | completed | Phase 2 | 70 | Neovii BiotechINDUSTRY | 4 | Dec 4, 2013 | clinicaltrials |
| NCT01388790 | Cetuximab in Combination With S-1 and Cisplatin in Gastric Cancer | completed | Phase 2 | 40 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 1 | Nov 20, 2013 | clinicaltrials |
| NCT00767377 | Continuous Infusion of FU Combined With Epirubicin and Oxaliplatin in Patients With A/MGC | completed | Phase 2 | 163 | Fudan UniversityOTHER | 1 | Oct 16, 2013 | clinicaltrials |
| NCT00003192 | Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagus | completed | Phase 2 | 15 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00632268 | Low-dose RAD001(Everolimus) Plus Cisplatin-HDFL Chemotherapy for the First-line Treatment of Advanced Gastric Cancer | completed | Phase 2 | 40 | National Taiwan University HospitalOTHER | 1 | Aug 21, 2013 | clinicaltrials |
| NCT00009880 | Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach | completed | Phase 2 | — | Radiation Therapy Oncology GroupNETWORK | 1 | Jul 19, 2013 | clinicaltrials |
| NCT00054249 | T900607 in Treating Patients With Gastroesophageal Junction Cancer | completed | Phase 2 | — | University Hospitals Seidman Cancer CenterOTHER | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00166881 | Weekly Docetaxel/Irinotecan for Non-resectable Gastric Cancers After Cisplatin Plus 5-FU/Leucovorin(P-HDFL-DI) | completed | Phase 2 | 29 | National Taiwan University HospitalOTHER | 1 | Jul 8, 2013 | clinicaltrials |
| NCT01118845 | Study of SyB L-0501 in Combination With Rituximab to Treat Relapsed/Refractory Diffuse Large B-Cell Lymphoma | completed | Phase 2 | 63 | SymBio PharmaceuticalsINDUSTRY | 2 | Jul 4, 2013 | clinicaltrials |
| NCT00002783 | Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach Cancer | completed | Phase 2 | 50 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT01517009 | A Multicenter Phase II Study of Neoadjuvant Docetaxel, Cisplatin and Capecitabine and Protocolized Surgery in Resectable Gastric Cancer(DoCCS) | completed | Phase 2 | 50 | Jeroen Bosch ZiekenhuisOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00032123 | Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer | completed | Phase 2 | — | SWOG Cancer Research NetworkNETWORK | 2 | Jun 24, 2013 | clinicaltrials |
| NCT00003055 | Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00003172 | Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer | completed | Phase 2 | — | Eastern Cooperative Oncology GroupNETWORK | 2 | Jun 21, 2013 | clinicaltrials |
| NCT00005599 | Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00006038 | Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00017056 | BMS-247550 in Treating Patients With Recurrent Metastatic Stomach Cancer That Has Been Previously Treated With Chemotherapy | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 18, 2013 | clinicaltrials |
| NCT00084604 | Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma | completed | Phase 2 | 47 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00062257 | Irofulven in Treating Patients With Recurrent or Metastatic Gastric Cancer | completed | Phase 2 | — | Cancer Therapeutics Research GroupOTHER | 4 | May 15, 2013 | clinicaltrials |
| NCT01851941 | A Phase II Trial of Perioperative Chemotherapy With Oxaliplatin, 5-Fluorouracil, Leucovorin(MODIFIED FOLFOX6) in Patients With Locally Advanced Operable Gastric Cancer | completed | Phase 2 | 52 | Seoul National University HospitalOTHER | 1 | May 13, 2013 | clinicaltrials |
| NCT01238055 | Sunitinib + Docetaxel as Second-line Treatment in Gastric Cancer | completed | Phase 2 | 116 | Samsung Medical CenterOTHER | 1 | Apr 9, 2013 | clinicaltrials |
| NCT00017043 | BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapy | completed | Phase 2 | — | Bristol-Myers SquibbINDUSTRY | 1 | Apr 5, 2013 | clinicaltrials |
| NCT01824004 | Postoperative Chemoradiotherapy With S-1 in Gastric Cancer | completed | Phase 2 | 46 | Chonnam National University HospitalOTHER | 1 | Apr 4, 2013 | clinicaltrials |
| NCT01659619 | Effect of Erythromycin Before Endoscopy of Patients With Subtotal Gastrectomy (STG), High Risk of Gastric Stasis | completed | Phase 2 | 114 | The Catholic University of KoreaOTHER | 1 | Feb 21, 2013 | clinicaltrials |
| NCT00733616 | Efficacy and Safety Study of Combination Therapy With Docetaxel-oxaliplatin-capecitabine in Patients With Advanced Gastric Adenocarcinoma and Intermediate General Status | completed | Phase 2 | 44 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)OTHER | 1 | Feb 20, 2013 | clinicaltrials |
| NCT00004127 | Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach | completed | Phase 2 | 35 | University of ChicagoOTHER | 2 | Feb 11, 2013 | clinicaltrials |
| NCT00103324 | S0413 Lapatinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Jan 17, 2013 | clinicaltrials |
| NCT00816543 | Docetaxel + Oxaliplatin + S-1 in Potentially Operable Gastric or Gastroesophageal Adenocarcinoma | completed | Phase 2 | 41 | SanofiINDUSTRY | 1 | Dec 18, 2012 | clinicaltrials |
| NCT00275951 | Cetuximab Plus P-HDFL for the First-line Treatment of Advanced Gastric Cancer(FLAG) | completed | Phase 2 | 39 | National Taiwan University HospitalOTHER | 1 | Nov 16, 2012 | clinicaltrials |
| NCT00514020 | Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer | completed | Phase 2 | 33 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Nov 1, 2012 | clinicaltrials |
| NCT00737373 | Oxaliplatin and 5-Fluorouracil With or Without Docetaxel in Elderly Patients (>65 y) With Stomach and Esophagus Cancer | completed | Phase 2 | 143 | Krankenhaus NordwestOTHER | 1 | Sep 19, 2012 | clinicaltrials |
| NCT00006081 | Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer | completed | Phase 2 | 37 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Dec 31, 2014source: clinicaltrials